Measles/Rubella Case Investigation Form
The XVII Meeting of the Technical Advisory Group (TAG) on Vaccine-preventable Diseases of the Pan American Health Organization (PAHO) was held from 25-27 July 2006 in Guatemala City, Guatemala. The TAG recognized the substantial progress achieved by member countries since the last meeting in 2004, and the high quality presentations and abstracts at this meeting. This meeting focused on the new challenges involving the transition from child to family immunization. In addressing this unfinished agenda –protecting achievements and facing new challenges– representatives from countries of the Region of the Americas shared their experiences since the last TAG.
This PAHO/WHO statement provides results of the investigation of serious adverse events that occurred in October 2007 following administration of yellow fever vaccine (17DD substrain) manufactured by Bio-Manguinhos, Brazil.
A previous PAHO/WHO statement on the reported events was issued on 2 November 2007 and recommended temporary suspension of specific lots of the vaccine.
This document describes the guidelines of the Pan American Health Organization (PAHO) for evaluating the Expanded Program on Immunization (EPI) at the country level. It is a response to the countries’ need to improve the use of their technical and financial resources, to the recommendations of the Technical Advisory Group of the EPI, and to the mandates of the governments of the countries of the Hemisphere themselves.
Regional Office for the Americas of the World Health Organization